Literature DB >> 19704391

Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner.

Ann N Burchell1, Pierre-Paul Tellier, James Hanley, François Coutlée, Eduardo L Franco.   

Abstract

BACKGROUND: We evaluated the influence of the partner's human papillomavirus (HPV) status and sexual practices on prevalent HPV infection among new couples to study HPV transmission.
METHODS: Women attending university or college in Montreal, Canada, and their male partners (N = 263 couples) were enrolled in 2005-2008. HPV typing was done in self-collected vaginal swabs and clinician-collected penis and scrotum swabs. The outcome measures were overall and type-specific HPV prevalence.
RESULTS: HPV was detected in 56% of women and men. Prevalence was higher among persons with infected partners (85%) than in those whose partners were negative (19%). Type-specific detection was substantially higher among women (OR = 55.2, 95% CI: 38.0-80.1) and men (OR = 58.7, 95% CI: 39.8-86.3) if their partner harbored the type under consideration. Prevalence among women and men with 10 or more lifetime partners was 15.4 (95% CI: 5.9-40.2) and 9.5 (95% CI: 4.4-19.8) times higher than among those with 1 partner. Frequent condom use was protective in men, particularly if his partner was HPV-infected (OR = 0.64, 95% CI: 0.50-0.82). This effect was attenuated among women with an infected partner (OR = 0.88, 95% CI: 0.69-1.11).
CONCLUSIONS: The current partner's status was the most important risk factor for prevalent HPV infection. Condoms exerted a stronger protective effect among men than among women.

Entities:  

Mesh:

Year:  2010        PMID: 19704391      PMCID: PMC8311542          DOI: 10.1097/OLQ.0b013e3181b35693

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  45 in total

1.  The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom.

Authors:  Joshua R Mann; Curtis C Stine; John Vessey
Journal:  Sex Transm Dis       Date:  2002-06       Impact factor: 2.830

2.  A stratified approach to untangling the behavioral/biomedical outcomes conundrum.

Authors:  Sevgi O Aral; Thomas A Peterman
Journal:  Sex Transm Dis       Date:  2002-09       Impact factor: 2.830

3.  HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.

Authors:  T C Wright; L Denny; L Kuhn; A Pollack; A Lorincz
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

Review 4.  Prevalence of HPV infection among men: A systematic review of the literature.

Authors:  Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

5.  Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers.

Authors:  D B Thomas; R M Ray; J Kuypers; N Kiviat; A Koetsawang; R L Ashley; Q Qin; S Koetsawang
Journal:  Am J Epidemiol       Date:  2001-04-15       Impact factor: 4.897

6.  Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Authors:  J W Sellors; A T Lorincz; J B Mahony; I Mielzynska; A Lytwyn; P Roth; M Howard; S Chong; D Daya; W Chapman; M Chernesky
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

7.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

8.  Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.

Authors:  Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana C Rodriguez; Robert D Burk
Journal:  J Infect Dis       Date:  2005-05-02       Impact factor: 5.226

9.  Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection.

Authors:  Ali Rowhani-Rahbar; James P Hughes; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2009-04       Impact factor: 2.830

10.  Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.

Authors:  Anna R Giuliano; Robin Harris; Rebecca L Sedjo; Susie Baldwin; Denise Roe; Mary R Papenfuss; Martha Abrahamsen; Paula Inserra; Sandra Olvera; Kenneth Hatch
Journal:  J Infect Dis       Date:  2002-08-02       Impact factor: 5.226

View more
  16 in total

1.  Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis.

Authors:  Ann N Burchell; Allita Rodrigues; Veronika Moravan; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples.

Authors:  Michel D Wissing; Karolina Louvanto; Emilie Comète; Ann N Burchell; Mariam El-Zein; Allita Rodrigues; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

3.  Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.

Authors:  Talía Malagón; Karolina Louvanto; Michel Wissing; Ann N Burchell; Pierre-Paul Tellier; Mariam El-Zein; François Coutlée; Eduardo L Franco
Journal:  Lancet Infect Dis       Date:  2019-02-10       Impact factor: 25.071

4.  Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) .

Authors:  Dr M Dawar; Ms T Harris; Dr S McNeil
Journal:  Can Commun Dis Rep       Date:  2012-01-02

5.  Directionality of Genital Human Papillomavirus Infection Transmission Within Heterosexual Couples: A Systematic Review and Meta-analysis.

Authors:  Rajshree Balaji; Aaron MacCosham; Khandideh Williams; Mariam El-Zein; Eduardo L Franco
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

6.  Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR.

Authors:  Véronique Legault; Ann Burchell; Patricia Goggin; Belinda Nicolau; Paul Brassard; Julie Guenoun; Pierre Forest; Marie-Hélène Mayrand; Eduardo Luis Franco; Francois Coutlée
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

7.  Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Authors:  Emmanuel Chandler; Lili Ding; Pamina Gorbach; Eduardo L Franco; Darron A Brown; Lea E Widdice; David I Bernstein; Jessica A Kahn
Journal:  J Adolesc Health       Date:  2018-07       Impact factor: 5.012

8.  Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study.

Authors:  Michel D Wissing; Ann N Burchell; Mariam El-Zein; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-05       Impact factor: 4.254

9.  Human papillomavirus infections among couples in new sexual relationships.

Authors:  Ann N Burchell; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Authors:  Agnihotram V Ramanakumar; Otelinda Goncalves; Harriet Richardson; Pierre Tellier; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.